ERBB2 and breast cancer: BC is a heterogeneous disease classified into four primary subtypes, including ER/PR+ and Her2− with Luminal A; ER/PR+ and Her2+ with Luminal B; and ER/PR−, Her2+ and ER/PR−, Her2− with triple-negative/basal-like tumors [6].